Filing Details

Accession Number:
0001140361-17-007988
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-16 17:35:12
Reporting Period:
2017-02-14
Filing Date:
2017-02-16
Accepted Time:
2017-02-16 17:35:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881524 Vivus Inc VVUS Pharmaceutical Preparations (2834) 943136179
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557543 North Tide Capital, Llc 500 Boylston Street
Suite 1860
Boston MA 02116
No No Yes No
1594068 Conan Laughlin 500 Boylston Street
Suite 1860
Boston MA 02116
Yes No Yes No
1594882 North Tide Capital Master, Lp 500 Boylston Street
Suite 1860
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-14 115,000 $1.10 12,653,890 No 4 S Indirect See Footnote
Common Stock Disposition 2017-02-15 40,090 $1.11 12,613,800 No 4 S Indirect See Footnote
Common Stock Disposition 2017-02-16 20,000 $1.11 12,593,800 No 4 S Indirect See Footnote
Common Stock Disposition 2017-02-16 130,000 $1.10 12,463,800 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. North Tide Capital, LLC ("North Tide") serves as investment manager for North Tide Capital Master, LP (the "Master Fund") and a managed account (the "Account"). Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
  2. Of the shares sold on February 14, 2017, 106,342 shares were held for the account of the Master Fund, 8,658 shares were held for the Account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin.
  3. Of the shares sold on February 15, 2017, 37,072 shares were held for the account of the Master Fund, 3,018 shares were held for the Account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin.
  4. Of the shares sold on February 16, 2017 at a price of $1.1125, 18,494 shares were held for the account of the Master Fund, 1,506 shares were held for the account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin.
  5. Of the shares sold on February 16, 2017 at a price of $1.1, 120,213 shares were held for the account of the Master Fund, 9,787 shares were held for the account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin. As of February 16, 2017, 10,901,895 shares were held for the account of the Master Fund, 1,561,905 shares were held for the account of the Account, and all of such shares may be deemed beneficially owned by North Tide and Mr. Laughlin.